Radiotherapy in early stage Hodgkin's disease: Principles and results of recent clinical trials

Annals of Oncology

Volumn 9, Issue SUPPL. 5, 1998, Pages

  Noordijk, E M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chemotherapy; Combined modality treatment; Early stages; Hodgkin's disease; Induced tumours; Late toxicity; Radiotherapy

Indexed keywords

BLEOMYCIN; CHLORMETHINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; HEART INFARCTION; HODGKIN DISEASE; HUMAN; INFRARED RADIATION; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION FIELD; RADIATION INJURY; SECOND CANCER;

EID: 0032447872     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/9.suppl_5.S63     Document Type: Conference Paper

References (15)

1. Henry-Amar M, Joly F. Late complications after Hodgkin's disease. Ann Oncol 1996; 7 (Suppl 4): 115-26.
2. Longo DL, Glatstein E, Duffey PL et al. Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: Seven-year results of a prospective randomized trial. J Clin Oncol 1991; 9: 906-17.
3. Biti GP, Cimino G, Cartoni C et al. Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: Eight-year update of an Italian prospective randomized study. J Clin Oncol 1992; 10: 378-82.
4. Longo DL. Chemotherapy alone in the treatment of patients with early stage Hodgkin's disease. Ann Oncol 1996; 7 (Suppl 4): 85-9.
5. Reuß K, Engert A, Tesch H et al. Current clinical trials in Hodgkin's disease. Ann Oncol 1996; 7 (Suppl 4): 109-13.
6. Pavlovsky S, Maschio M, Santarelli M et al. Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage I-II Hodgkin's disease. J Natl Cancer Inst 1988; 80: 1466-73.
7. Noordijk EM, Carde P, Mandard A-M et al. Preliminary results of the EORTC-GPMC controlled clinical trial H7 in early-stage Hodgkin's disease. Ann Oncol 1994; 5: 107-12.
8. Leibenhaut MH, Hoppe RT, Efron B et al. Prognostic indicators of laparotomy findings in clinical stage I-II supradiaphragmatic Hodgkin's disease. J Clin Oncol 1989; 7: 81-91.
9. Manch P, Larson D, Osteen R et al. Prognostic factors for positive surgical staging in patients with Hodgkin's disease. J Clin Oncol 1990; 8: 257-65.
10. Gospodarowicz MK, Sutcliffe SB, Clark RM et al. Analysis of supradiaphragmatic clinical stage I and II Hodgkin's disease treated with radiation alone. Int J Radiat Oncol Biol Phys 1992; 22: 859-65.
11. Noordijk EM, Carde P, Hagenbeek A et al. Combination of radiotherapy and chemotherapy is advisable in all patients with clinical stage I-II Hodgkin's disease. Six-year results of the EORTC-GPMC controlled clinical trials 'H7-VF', 'H7-F' and 'H7-U'. Int J Radial Oncol Biol Phys 1997; 39 (Suppl 2): 173.
12. Dühmke E, Diehl V, Loeffler M et al. Randomized trial with early-stage Hodgkin's disease testing 30 Gy vs. 40 Gy extended field radiotherapy alone. Int J Radiat Oncol Biol Phys 1996; 36: 305-10.
13. Diehl V, Pfreundschuh M, Löffler M et al. Cooperative trials of Hodgkin's lymphoma in the Federal Republic of Germany. J Cancer Res Clin Oncol 1990; 116: 106-8.
14. Shore T, Nelson N,Wienerman B. A meta-analysis of stages I and II Hodgkin's disease. Cancer 1990; 65: 1155-60.
15. Specht L, Carde P, Mauch P et al. Radiotherapy versus combined modality in early stages. Ann Oncol 1992; 3: 77-81.